← SynDRA
CGP-20712A
SynDRA canonical compound SYN0001609 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ADRB1 |
| Mechanism of action | Adrenergic receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRB1 ANTAGONIST
- ADRB3 ANTAGONIST
Drug classes
- Adrenergic beta-Antagonists
Cross-references
Synonyms
- GKJZEKSHCJELPL-UHFFFAOYSA-N
- CGP-20712
- CGP20712A
- C23H25F3N4O5
- 2-hydroxy-5-{2-[(2-hydroxy-3-{4-[1-methyl-4-(trifluoromethyl)-1h-imidazol-2-yl]phenoxy}propyl)amino]ethoxy}benzamide
- Cgp 26505
- Cgp-20712-A
- 2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenoxy]propyl]amino]ethoxy]benzamide
- SR-01000076208
- 2-Hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenoxy]propyl]amino]ethoxy]benzamide
- Cgp-20712
- SIO2UEZ19H
- RefChem:918314
- CGP 20712 A
- UNII-SIO2UEZ19H
- cid_2685
- Lopac0_000364
- GTPL541
- orb1697871
- SCHEMBL10914264
- SCHEMBL29709203
- BDBM25746
- CHEBI:91628
- PDSP1_000800
- PDSP1_000801
- PDSP2_000788
- AKOS032953953
- CCG-204459
- SDCCGSBI-0050352.P002
- NCGC00024944-02
- NCGC00024944-03
- NCGC00024944-04
- NCGC00024944-08
- TS-08695
- HY-101355
- CS-0021207
- T30846
- L000167
- SR-01000076208-7
Look up CGP-20712A in the interactive SynDRA portal →